⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Clonal Hematopoiesis
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-10 — Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.: cross-connection with bone-marrow-adipose-tissue: Framing marrow adipocytes as niche remodelers of inflammatory hematopoiesis connects BMAT biology to the hematopoietic-clonal-expansion drivers of age-related cardiovascular risk. (novelty: 3)
- 2026-07-16 — Clonal haematopoiesis of indeterminate potential and epigenetic age acceleration: Systematic review and meta-analysis.: 2026 systematic review and meta-analysis (~7,000 participants) quantifies CHIP–epigenetic age acceleration association across Horvath, Hannum, PhenoAge, and GrimAge, with TET2-mutant clones and higher VAF driving larger effects than DNMT3A — first pooled driver-stratified and clone-size-stratified link between CHIP and multi-clock methylation aging. [human-observational] (novelty: 3)
- 2026-08-12 — Clonal hematopoiesis of undetermined potential as an emerging determinant of inflammageing, and age-related diseases: Potential role as biomarker and target.: 2026 review synthesizes CHIP as an emerging determinant of inflammaging and age-related disease risk with biomarker and pharmacological-target framing, while explicitly noting that validated risk models, screening pathways, and clinical translation remain limited — consolidation of an emerging geroscience theme, not a primary trial. [expert-opinion] (novelty: 3)
- 2026-09-16 — Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.: Human observational multi-omic profiling: high-VAF DNMT3A-mutant CH shows LINE/LTR retrotransposable-element derepression coupled to TNF-α/NF-κB, interferon, and senescence signatures, while TET2-mutant CH lacks RTE inflammation and instead enriches OXPHOS, ROS, and mTORC1 — a mutation-specific mechanistic split within the CH umbrella. [human-observational] (novelty: 3)
- 2026-07-31 — Haploidentical Hematopoietic Stem Cell Transplantation Drives Time-dependent premature T Cell Senescence: Recipient Microenvironment Modulates Donor T Cell Epigenetic Aging, Telomere Homeostasis and SASP Remodeling.: cross-connection with cellular-senescence: HSCT-induced premature T-cell senescence and SASP remodeling sit adjacent to clonal-hematopoiesis biology as hematopoietic-compartment aging phenomena shaped by donor–recipient microenvironment interactions. (novelty: 3)
- 2026-07-09 — Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.: cross-connection with pink1-parkin-mitophagy: The NAD⁺-dependent HSC mitophagy checkpoint invoked in this review links mitochondrial ubiquitination QC to hematopoietic stem-cell fate, providing a mechanistic bridge to clonal hematopoiesis biology. (novelty: 3)
- 2026-07-28 — The OmniAge compendium of aging omic biomarkers links mitotic clocks to clonal hematopoiesis and causality.: 2026 OmniAge compendium (413 aging omic biomarkers) reports that mitotic-clock acceleration associates with specific clonal hematopoiesis subtypes in blood, and that overlapping ‘causal’ clocks in the panel predict cancer risk — observational human data, no intervention arm. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.
16-sep-2026
novelty 3
per-area 3
strengthens
Clonal hematopoiesis of undetermined potential as an emerging determinant of inflammageing, and age-related diseases: Potential role as biomarker and target.
12-aug-2026
novelty 3
per-area 3
strengthens
The OmniAge compendium of aging omic biomarkers links mitotic clocks to clonal hematopoiesis and causality.
28-jul-2026
novelty 3
per-area 3
strengthens
Clonal haematopoiesis of indeterminate potential and epigenetic age acceleration: Systematic review and meta-analysis.
16-jul-2026
novelty 3
per-area 3
strengthens
Aging, Geriatric Syndromes and Clonal Hematopoiesis
13-jul-2026
novelty 2
per-area 2
mentions